Unlock instant, AI-driven research and patent intelligence for your innovation.

Fluid infusion culture medium and method for culturing and inducing hematopoietic stem cells to differentiate into megakaryocyte cells

A technology of hematopoietic stem cells and medium, applied in the field of bioengineering, can solve the problems of low induction differentiation efficiency and weak proliferation ability

Pending Publication Date: 2021-06-25
ACADEMY OF MILITARY MEDICAL SCI +1
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] However, the current system for promoting the induction and differentiation of hematopoietic stem cells into megakaryocytes still has problems such as weak proliferation ability and low induction differentiation efficiency.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Fluid infusion culture medium and method for culturing and inducing hematopoietic stem cells to differentiate into megakaryocyte cells
  • Fluid infusion culture medium and method for culturing and inducing hematopoietic stem cells to differentiate into megakaryocyte cells
  • Fluid infusion culture medium and method for culturing and inducing hematopoietic stem cells to differentiate into megakaryocyte cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0071] Materials and methods

[0072] 1. Main materials

[0073] stemspan TM II serum-free medium is the product of stemcell company;

[0074] Recombinant human thrombopoietin injection is Shenyang Sansheng Pharmaceutical Co., Ltd.;

[0075] SCF, IL-3, and IL-6 are all products of RD;

[0076] Aryl hydrocarbon receptor antagonist (SR1) is a product of stemcell;

[0077] P188 is a product of sigma company;

[0078] CD41-APC, CD61a-FITC antibodies are ebiscience antibodies;

[0079] Umbilical cord blood comes from Beijing Cord Blood Bank;

[0080] VI-CELL cell viability analyzer is a product of BECKMAN;

[0081]The G-Rex 10 culture device is a product of Wilson Wolf Manufacturing in the United States;

[0082] Wright-Giemsa staining was a product of BASO.

[0083] High-pressure liquid chromatography: Shimadzu Corporation, Japan.

[0084] 2. Cord blood mononuclear cells: mix cord blood with 6% hydroxyethyl starch, settle red blood cells for 20-30 minutes, take supernata...

Embodiment 2

[0101] Example 2 Effects of Amino Acids on the Induced Differentiation of Umbilical Cord Blood Mononuclear Cells to Megakaryocytes

[0102] 1. Materials

[0103] The materials used in this embodiment are the same as those in Embodiment 1, and will not be repeated here.

[0104] Amino acid configuration:

[0105] Aspartic acid L-ASparagine (Asp): 1M HCl configuration, mother solution concentration 757mM, culture system final concentration 124μM;

[0106] L-cysteine ​​(Cyss): H 2 O configure the mother solution concentration of 206.3mM, and the final concentration of the culture system is 44μM;

[0107] Serine L-serine (Ser): H 2 O is used to configure the concentration of the mother solution to be 475.78mM, and the final concentration of the culture system to be 350μM.

[0108] 2. Induction of differentiation of umbilical cord blood mononuclear cells into megakaryocytes

[0109] The isolated umbilical cord blood mononuclear cells were divided into 5×10 5 piece / cm 2 Inoc...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
Login to View More

Abstract

The invention provides a fluid infusion culture medium and a method for inducing hematopoietic stem cells to differentiate into megakaryocyte cells. The culture medium comprises a basic culture medium; a thrombopoietin; recombinant human stem cell factors; interleukin-3; iterleukin-6; a poloxamer 188; an aromatic hydrocarbon receptor antagonist; a granulocyte macrophage colony stimulating growth factor; interleukin-11 and amino acid. The fluid infusion culture medium can better promote hematopoietic stem cells to be differentiated into megakaryocyte cells, the differentiation efficiency and the yield and activity of the megakaryocyte cells are improved, and the fluid infusion culture medium has wide application prospects.

Description

technical field [0001] The invention relates to the field of bioengineering. Specifically, the present invention relates to a rehydration medium and a method for inducing hematopoietic stem cells to differentiate into megakaryocytes. Background technique [0002] Platelets are produced by the cytoplasm of mature megakaryocytes in the bone marrow and have the functions of coagulation and capillary protection. Abnormal platelets can lead to bleeding disorders. In recent years, the incidence of tumors has been increasing year by year. Radiotherapy and chemotherapy are commonly used methods for tumor treatment, often accompanied by symptoms of thrombocytopenia. Clinically, platelet transfusion is used as the main treatment, but blood supply is tight, or repeated platelet transfusions are ineffective. Prompting people to explore new sources of platelets. Hematopoietic stem cells can differentiate into megakaryotic progenitor cells in vitro, and gradually mature into platelets, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/0789C12N5/078
CPCC12N5/0644C12N5/0647C12N2501/145C12N2501/125C12N2501/2303C12N2501/2306C12N2501/22C12N2501/2311C12N2500/32C12N2500/50C12N2501/06
Inventor 习佳飞岳文裴雪涛陈琳李艳华吕洋范增姚海雷南雪李雪张博文何丽娟
Owner ACADEMY OF MILITARY MEDICAL SCI